Canada’s regulatory approach to drugs for rare diseases: orphan drugs

Canada’s regulatory approach to drugs for rare diseases: orphan drugs is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2023-12-02. On CanQuery you can follow the original downloads. Files are available in English and French.

Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-12-02

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data